DINAH SINGER and WARREN KIBBE were named acting deputy directors of NCI.
With a growing backlog at NIH and Columbia University’s grants getting canceled over alleged antisemitism, where does that leave NCI-designated cancer centers?
Singer, Kibbe Named Acting NCI Deputy Directors
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
How are cancer centers in two rural states—Kansas and South Carolina—weathering the challenges of Trump-era belt-tightening and uncertainty? Their directors weigh in on The Cancer Letter Podcast.
Government work isn’t what it used to be.
I was really excited to get to talk about the role that mentorship plays in women’s leadership development. It’s a topic that I’ve thought a lot about, and also that I’ve benefitted from, and that I think is not always applied with enough intention. There is an art to mentorship, and I want to share some of how that has helped me navigate career transitions and pivot to leadership roles.
As we are all aware, the new presidential administration is moving rapidly to change how science, including health sciences, will be conducted and funded by the federal government, including research supported by the National Institutes of Health.
As a physician-scientist who has navigated drug development from lab bench to bedside to executive boardroom, I want to touch upon a subject that is near and dear to my heart: the state of American science—a linchpin of our healthcare system and national competitiveness.
